论文部分内容阅读
心室同步化治疗已经成为慢性心力衰竭的非药物治疗手段,但心室同步化治疗的指征仍然存在争议,有近30%的病人效果不佳。近年来,美国心脏病学会/美国心脏协会(ACC/AHA)和欧洲心脏学会(ESC)等学会均不断更新心室同步化治疗的指南,对临床治疗效果的评估、超声心动图在指征和术后效果临床评估中的作用、同步化治疗无反应的病人的甄别及其影响因素等方面均有不同的研究报道。
Ventricular synchrony therapy has become a non-drug treatment for chronic heart failure, but the indications for ventricular synchronized therapy remain controversial, with nearly 30% of patients unsuccessful. In recent years, the American College of Cardiology / American Heart Association (ACC / AHA) and the European Society of Cardiology (ESC) and other societies continue to update guidelines for the treatment of ventricular synchrony, the evaluation of clinical treatment, echocardiography in the indications and surgery Post-clinical evaluation of the role of the effect of synchronization of non-response patients with screening and its influencing factors, there are different studies reported.